New Zealand markets closed

Aelis Farma SA (AELIS.PA)

Paris - Paris Delayed price. Currency in EUR
Add to watchlist
13.10+0.10 (+0.77%)
At close: 09:23AM CEST
Full screen
Previous close13.00
Open13.00
BidN/A x N/A
AskN/A x N/A
Day's range13.00 - 13.10
52-week range12.80 - 14.10
Volume350
Avg. volume352
Market cap171.682M
Beta (5Y monthly)0.12
PE ratio (TTM)N/A
EPS (TTM)-0.39
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est20.70
  • Business Wire

    Aelis Farma Announces the Last Patient, Last Visit in its Clinical Phase 2b Trial with AEF0117 for the Treatment of Cannabis Use Disorder

    BORDEAUX, France, April 18, 2024--Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS), a clinical-stage biopharmaceutical company specializing in the development of treatments for brain diseases, is pleased to announce today a significant milestone in the clinical development of AEF0117: the last patient visit in the clinical phase 2b study, which included 333 individuals seeking treatment for cannabis use disorder (CUD), has been completed.

  • Business Wire

    Aelis Farma Reports Its 2023 Annual Financial Resultsand Confirms Its 2024 Outlook

    BORDEAUX, France, April 02, 2024--Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases, today announces its full year results for the year to December 31, 2023.

  • Business Wire

    Aelis Farma Announces Its 2024 Financial Calendar

    BORDEAUX, France, January 30, 2024--Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS), a clinical-stage biopharmaceutical company specializing in the development of treatments for brain diseases, today announces its indicative financial calendar for the financial year 2024.